Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05227144
Title Study of ORIC-533 in Relapsed or Refractory Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors ORIC Pharmaceuticals
Age Groups: adult | senior
Covered Countries USA | CAN

No variant requirements are available.